JPMorgan sees shares of Procter & Gamble rising 11% from current levels.
Get this delivered to your inbox, and more info about our products and services.
JPMorgan downgraded Procter & Gamble to neutral from overweight ahead of the company's next quarterly earnings report.
P&G's resurgence is driven not just by the market rotation but also by improving fundamentals.
The bank foresees upside of 29% ahead for the stock.
P&G was able to do this despite increased commodity prices due to the Iran war.
JPMorgan's list of top stock picks heading into May include new additions PTC Therapeutics and Armstrong World Industries.
The bank upgraded its rating on Capital One Financial, citing its cheaper valuation after a fall in 2026 and ability to manage a…
